Clinical outcomes of supra-bony defects treated with access flap and enamel matrix derivative or access flap alone: a 12-months randomized controlled clinical study

niversity Federico II0 个研究点目标入组 80 人开始时间: 2019年2月21日最近更新: 2021年10月4日

适应症

试验速览

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32562077/ (added 24/09/2021)

•1. Patients suffering from chronic periodontitis;
•2. Age =18 years old
•3. Presence of supra-alveolar-type defects (i.e. defects displaying a predominantly horizontal pattern of bone loss) at a minimum of two adjacent teeth and a maximum of 7 adjacent teeth (FDI positions 15-25 or 35-45) in either the maxilla or the mandible with a PD = 6 mm at a minimum on one site of examined teeth.
•4. Intrabony defect with an intrabony component of < 2 mm;

•1. Patients with systemic disease
•2. Prolonged antibiotic treatment or anti-inflammatory treatment within 4 weeks prior to surgery
•3. Pregnant or lactating
•4. Tobacco smokers
•5. Patients with FMPS and FMBS ? 25 % after completion of non surgical periodontal therapy recorded at six sites per tooth)
•6. Intra-bony defects = 2 mm or involving furcation involvement;
•7. Presence of prothesis reconstructions
•8. Multi-rooted teeth

发起方

niversity Federico II